-- "The rot at Harvard clearly runs much deeper than previously guessed. The Dana-Farber Cancer Institute in Boston, a Harvard-affiliated teaching hospital, is retracting six papers and seeking to correct dozens more by four of its top researchers — including the hospital’s CEO, COO and two program directors." --
